NCT04992728Recruiting
Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI
Quantitative Diffusion MRI for Prostate Cancer Detection and Monitoring
Source: ClinicalTrials.gov · Last updated 6 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This single-center study will enroll 40 male participants to complete 2 diffusion magnetic resonance images within 30 days of each other.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 28 Jul 2021
- Start date
- 2 Nov 2021
- Primary completion date
- 1 Nov 2025
- Lead sponsor
- University of California, San Diego
- Diseases
- Prostate cancer
- NCT number
- NCT04992728
What you commit to
- Study type: Observational
- Planned participants: 100
- From 2 Nov 2021 to the primary completion date, 1 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior treatment for prostate cancer (cryotherapy, high frequency focused ultrasound, prostatectomy)
Lab values
- Patient has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the trial, interfere with the subject's participation for the full duration of the trial, or is not in the best interest of the subject to participate, in the opinion of the treating investigator.
Other
- Hip prosthesis
- Contraindication to MRI, per institutional requirements
Who the study is looking for
- Male, aged ≥18 years, with histologically confirmed adenocarcinoma of the prostate
- Has already undergone prostate MRI and/or scheduled to undergo clinically indicated radical prostatectomy (to permit whole-mount histopathology correlation).
- Intended treatment and follow-up according to standard of care for prostate cancer
- In good general health as evidenced by medical history and ECOG performance status 0-2
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UCSD Moores Cancer Center Coordinator of this site? Confirm its status | La Jolla | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.